NASDAQ:HALO Shareholder Alert: Investigation over Potential Wrongdoing at Halozyme Therapeutics, Inc
An investigation was announced for investors in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) over potential breaches of fiduciary duties by certain officers and directors at Halozyme Therapeutics.
View full press release